Halozyme Therapeutics, Inc. (FRA:RV7)
59.66
+0.66 (1.12%)
At close: Jan 27, 2026
Halozyme Therapeutics Employees
Halozyme Therapeutics had 350 employees as of December 31, 2024. The number of employees decreased by 23 or -6.17% compared to the previous year.
Employees
350
Change (1Y)
-23
Growth (1Y)
-6.17%
Revenue / Employee
€3,026,522
Profits / Employee
€1,450,108
Market Cap
7.10B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 350 | -23 | -6.17% |
| Dec 31, 2023 | 373 | -20 | -5.09% |
| Dec 31, 2022 | 393 | 248 | 171.03% |
| Dec 31, 2021 | 145 | 9 | 6.62% |
| Dec 31, 2020 | 136 | 4 | 3.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Paul Hartmann AG | 10,082 |
| Mainova AG | 3,416 |
| Gelsenwasser AG | 1,898 |
| Maschinenfabrik Berthold Hermle AG | 1,607 |
| EUROKAI GmbH & Co. KGaA | 950 |
| tonies SE | 567 |
| Lechwerke AG | 459 |
| Northern Data AG | 199 |